UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook

The veterinary active pharmaceutical ingredients manufacturing market in UK is expected to reach a projected revenue of US$ 602.0 million by 2030. A compound annual growth rate of 6.1% is expected of UK veterinary active pharmaceutical ingredients manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$398.5
Forecast, 2030 (US$M)
$602.0
CAGR, 2024 - 2030
6.1%
Report Coverage
UK

UK veterinary active pharmaceutical ingredients manufacturing market, 2018-2030 (US$M)

UK

Related Markets

UK veterinary active pharmaceutical ingredients manufacturing market highlights

  • The UK veterinary active pharmaceutical ingredients manufacturing market generated a revenue of USD 398.5 million in 2023 and is expected to reach USD 602.0 million by 2030.
  • The UK market is expected to grow at a CAGR of 6.1% from 2024 to 2030.
  • In terms of segment, in house was the largest revenue generating service type in 2023.
  • Contract Outsourcing is the most lucrative service type segment registering the fastest growth during the forecast period.


Veterinary active pharmaceutical ingredients manufacturing market data book summary

Market revenue in 2023USD 398.5 million
Market revenue in 2030USD 602.0 million
Growth rate6.1% (CAGR from 2023 to 2030)
Largest segmentIn house
Fastest growing segmentContract Outsourcing
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationIn House, Contract Outsourcing
Key market players worldwideZoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries


Other key industry trends

  • In terms of revenue, UK accounted for 4.6% of the global veterinary active pharmaceutical ingredients manufacturing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK veterinary active pharmaceutical ingredients manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • France is the fastest growing regional market in Europe and is projected to reach USD 513.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Companies

Name Profile # Employees HQ Website

UK veterinary active pharmaceutical ingredients manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.


In house was the largest segment with a revenue share of 62.74% in 2023. Horizon Databook has segmented the UK veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.


The veterinary API manufacturing market in the UK is anticipated to register lucrative growth over the forecast period. The increasing pet ownership and insurance coverage in the country is expected to drive market growth. Moreover, the number of insured pets is surging due to the prevalence of pet diseases.

The leading veterinary charity in the UK, People’s Dispensary for Sick Animals (PDSA), provides low-cost and free treatments to animals in need. It is common for pets to get hurt or ill. At PDSA charity animal hospitals, around 800 monthly cases requiring emergency surgery are reported.

Moreover, favorable agreements for animal trade are likely to augment market growth. For instance, the Intra Trade Animal Health Certificates aid in trading animals within the EU. It is mandatory for all animals being traded to have a health certificate, ensuring that they are disease-free.

Reasons to subscribe to UK veterinary active pharmaceutical ingredients manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UK veterinary active pharmaceutical ingredients manufacturing market databook

  • Our clientele includes a mix of veterinary active pharmaceutical ingredients manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UK veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into UK veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UK veterinary active pharmaceutical ingredients manufacturing market size, by service type, 2018-2030 (US$M)

UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

UK veterinary active pharmaceutical ingredients manufacturing market size, by service type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more